R&D Scientists and algorithms: Finding the right balance in mode... The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
Patients Reshaping the future of patient-centric drug development Strategic partnerships, robust quality systems, and manufacturing know-how will support next-generation therapies with patient-centric designs.
R&D European launch: Manufacturing as cornerstone for success In Europe, manufacturing may not make headlines in pharma partnering, but it’s one of the foundations on which strong partnerships must be built.
Sales & Marketing Sponsored What HCPs Say Pharma Gets Wrong About Survey Research Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.
R&D Manufacturers can streamline and speed the batch release pro... As of late November 2024, the US Food & Drug Administration had recorded 46 voluntary drug recalls in the United States during the year, down slightly from previous years – an indicatio
R&D Quality compliance in the digital era Quality compliance in the pharma industry is foundational to guaranteeing safe and effective products.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
